Relevant subtypes in childhood ALL

Chloé Arfeuille^{1

2}, Hélène Cavé^{1

2}

Affiliations

¹ Assistance Publique des Hôpitaux de Paris (AP-HP), Département de Génétique, Hôpital Robert Debré, Paris, France.
² INSERM UMR_S1131, Institut de Recherche Saint-Louis, Université de Paris, Paris, France.

Chloé Arfeuille et al. Hemasphere. 2019.

. 2019 Jun 30;3(Suppl):174-177.

doi: 10.1097/HS9.0000000000000245. eCollection 2019 Jun.

Chloé Arfeuille^{1

2}, Hélène Cavé^{1

2}

¹ Assistance Publique des Hôpitaux de Paris (AP-HP), Département de Génétique, Hôpital Robert Debré, Paris, France.
² INSERM UMR_S1131, Institut de Recherche Saint-Louis, Université de Paris, Paris, France.

No abstract available

References

1. Iacobucci I, Mullighan CG. Genetic basis of acute lymphoblastic leukemia. J Clin Oncol 2017; 35:975–983.Comprehensive and nicely presented review of BCP-ALL novel genetic subgroups. - PMC - PubMed
1. Moorman AV. The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia. Blood Rev 2012; 26:123–135. - PubMed
1. Frismantas V, Dobay MP, Rinaldi A, et al. . Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia. Blood 2017; 129:e26–e37. - PMC - PubMed
1. Gu Z, Churchman M, Roberts K, et al. . Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia. Nat Commun 2016; 7:13331. - PMC - PubMed
1. Alexander TB, Gu Z, Iacobucci I, et al. . The genetic basis and cell of origin of mixed phenotype acute leukaemia. Nature 2018; 562:373–379. - PMC - PubMed